ALX Oncology Holdings Inc. (ALXO) Tops Q4 EPS by 12c
Tweet
Share
E-mail
Get Alerts ALXO Hot Sheet
Join SI Premium – FREE
ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q4 EPS of ($0.55), $0.12 better than the analyst estimate of ($0.67).
For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
- Musalem: strong growth and investment influencing bond market - CNBC
- Etsy upgraded to buy at BofA on durable growth, buyback potential
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
